Collegium Pharmaceutical, Inc. announced that effective May 24, 2024, Joe Ciaffoni will step down as Chief Executive Officer (CEO) of the Company. Mr. Ciaffoni will serve as a member of the Board of Directors of the Company until the upcoming 2024 Annual Meeting of Shareholders and will not stand for re-election at the meeting. To ensure a seamless transition, Michael Heffernan, founder, former CEO and Chairman of the Board will serve as Interim CEO until a new CEO is appointed by the Board of Directors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.27 USD | -2.63% | -5.78% | +4.84% |
May. 13 | Collegium Pharmaceutical Launches $35 Million Accelerated Share Repurchase Program | MT |
May. 10 | Needham Downgrades Collegium Pharmaceutical to Hold From Buy | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.84% | 1.06B | |
+42.60% | 748B | |
+33.05% | 598B | |
-5.74% | 356B | |
+17.79% | 325B | |
+3.37% | 283B | |
+17.25% | 245B | |
+9.25% | 211B | |
-3.89% | 209B | |
+1.81% | 166B |
- Stock Market
- Equities
- COLL Stock
- News Collegium Pharmaceutical, Inc.
- Collegium Announces CEO Transition